IRIS Accounts Production v26.2.5.4 11599365 Board of Directors 1.1.25 31.12.25 31.12.25 1.9.26 false true false false true false Auditors Opinion iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh115993652024-12-31115993652025-12-31115993652025-01-012025-12-31115993652023-12-31115993652024-01-012024-12-31115993652024-12-3111599365ns15:EnglandWales2025-01-012025-12-3111599365ns14:PoundSterling2025-01-012025-12-3111599365ns10:Director12025-01-012025-12-3111599365ns10:PrivateLimitedCompanyLtd2025-01-012025-12-3111599365ns10:SmallEntities2025-01-012025-12-3111599365ns10:Audited2025-01-012025-12-3111599365ns10:SmallCompaniesRegimeForDirectorsReport2025-01-012025-12-3111599365ns10:SmallCompaniesRegimeForAccounts2025-01-012025-12-3111599365ns10:FullAccounts2025-01-012025-12-3111599365ns10:Director22025-01-012025-12-3111599365ns10:Director32025-01-012025-12-3111599365ns10:CompanySecretary12025-01-012025-12-3111599365ns10:RegisteredOffice2025-01-012025-12-3111599365ns5:CurrentFinancialInstruments2025-12-3111599365ns5:CurrentFinancialInstruments2024-12-3111599365ns5:ShareCapital2025-12-3111599365ns5:ShareCapital2024-12-3111599365ns5:RetainedEarningsAccumulatedLosses2025-12-3111599365ns5:RetainedEarningsAccumulatedLosses2024-12-3111599365ns5:ShortLeaseholdAssetsns5:LandBuildings2024-12-3111599365ns5:LeaseholdImprovements2024-12-3111599365ns5:PlantMachinery2024-12-3111599365ns5:FurnitureFittings2024-12-3111599365ns5:ShortLeaseholdAssetsns5:LandBuildings2025-01-012025-12-3111599365ns5:LeaseholdImprovements2025-01-012025-12-3111599365ns5:PlantMachinery2025-01-012025-12-3111599365ns5:FurnitureFittings2025-01-012025-12-3111599365ns5:ShortLeaseholdAssetsns5:LandBuildings2025-12-3111599365ns5:LeaseholdImprovements2025-12-3111599365ns5:PlantMachinery2025-12-3111599365ns5:FurnitureFittings2025-12-3111599365ns5:ShortLeaseholdAssetsns5:LandBuildings2024-12-3111599365ns5:LeaseholdImprovements2024-12-3111599365ns5:PlantMachinery2024-12-3111599365ns5:FurnitureFittings2024-12-3111599365ns5:WithinOneYearns5:CurrentFinancialInstruments2025-12-3111599365ns5:WithinOneYearns5:CurrentFinancialInstruments2024-12-31
REGISTERED NUMBER: 11599365 (England and Wales)











FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2025

FOR

E.M.S ELECTRO MEDICAL SYSTEMS UK LIMITED

E.M.S ELECTRO MEDICAL SYSTEMS UK LIMITED (REGISTERED NUMBER: 11599365)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025




Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 3


E.M.S ELECTRO MEDICAL SYSTEMS UK LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 DECEMBER 2025







DIRECTORS: C M L B Lanore
H L Morris
A J Siegrist





SECRETARY: Mrs D Brown





REGISTERED OFFICE: Nelson House
Alington Road
Little Barford
St Neots
Cambs
PE19 6RE





REGISTERED NUMBER: 11599365 (England and Wales)





AUDITORS: Bradshaw Johnson
Chartered Accountants
Statutory Auditor
Croft Chambers
11 Bancroft
Hitchin
Hertfordshire
SG5 1JQ

E.M.S ELECTRO MEDICAL SYSTEMS UK LIMITED (REGISTERED NUMBER: 11599365)

STATEMENT OF FINANCIAL POSITION
31 DECEMBER 2025

31.12.25 31.12.24
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 199,547 279,632

CURRENT ASSETS
Stocks 1,123,747 609,913
Debtors 5 646,647 640,895
Cash at bank 441,678 279,646
2,212,072 1,530,454
CREDITORS
Amounts falling due within one year 6 4,339,742 3,432,115
NET CURRENT LIABILITIES (2,127,670 ) (1,901,661 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

(1,928,123

)

(1,622,029

)

PROVISIONS FOR LIABILITIES - 53,578
NET LIABILITIES (1,928,123 ) (1,675,607 )

CAPITAL AND RESERVES
Called up share capital 1 1
Retained earnings (1,928,124 ) (1,675,608 )
(1,928,123 ) (1,675,607 )

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 4 August 2026 and were signed on its behalf by:





A J Siegrist - Director


E.M.S ELECTRO MEDICAL SYSTEMS UK LIMITED (REGISTERED NUMBER: 11599365)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025

1. STATUTORY INFORMATION

E.M.S Electro Medical Systems UK Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Going concern
The financial statements are prepared on a going concern basis. The Company remains assured of the financial support by the parent company. The directors have received confirmation that the parent company will continue to support the Company and provide it with adequate funds when necessary to enable it to meet its debts as they fall due in the foreseeable future. On this basis, the directors consider it appropriate to prepare the financial statements on a going concern basis.

Turnover
Turnover represents sales to external customers at amounts invoiced less value added tax and trade discounts. Turnover is recognised on dispatch of goods to customers.

Turnover is recognised to the extent that it is probable that the economic benefits will flow to the Company and the turnover can be reliably measured. Turnover is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before turnover is recognised:

Sale of goods
Turnover from the sale of goods is recognised when all of the following conditions are satisfied:
- the Company has transferred the significant risks and rewards of ownership to the buyer;
- the Company retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold;
- the amount of turnover can be measured reliably;
- it is probable that the Company will receive the consideration due under the transaction; and
- the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Commissions
Commissions are presented in other operating income with the Statement of comprehensive income. This relates to commissions receivable when acting as an agent for other companies within the group.

E.M.S ELECTRO MEDICAL SYSTEMS UK LIMITED (REGISTERED NUMBER: 11599365)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2025

2. ACCOUNTING POLICIES - continued

Tangible fixed assets
Tangible fixed assets under cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

At each reporting date the Company assesses whether there is any indication of impairment. If such indication exists, the recoverable amount of the asset is determined which is the higher of its fair value less costs to sell and its value in use. An impairment loss is recognised where the carrying amount exceeds the recoverable amount.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Leasehold improvements- 5 years
Plant and machinery- 3 years
Fixtures and fittings- 3 years
Loan assets- 5 years

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

Stocks
Stocks are stated at the lower of cost and net realisable value, being the estimated selling price less costs to complete and sell. Cost is based on the cost of purchase on first in, first out basis.

At each reporting date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in profit or loss.

Debtors
Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

Cash and cash equivalents
Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

Creditors
Short-term creditors are measured at the transaction price. Other financial liabilities are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.


E.M.S ELECTRO MEDICAL SYSTEMS UK LIMITED (REGISTERED NUMBER: 11599365)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2025

2. ACCOUNTING POLICIES - continued
Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Research and development
In the research phase on internal project it is not possible to demonstrate that the project will generate future economic benefits and hence all expenditure on research shall be recognised as an expense when it is incurred. Intangible assets are recognised from the development phase of a project if and only if certain specific criteria are met in order to demonstrate the asset will generate probable future economic benefits and that its cost can be reliably measured. The capitalised development costs are subsequently amortised on a straight-line basis over their useful economic lives, which range from 3 to 6 years.

If it is not possible to distinguish between the research phase and the development phase of an internal project, the expenditure is treated as if it were all incurred in the research phase only.

Foreign currencies
Foreign currency transactions are translated into the functions currency using the spot exchange rates at the dates of the transactions.

At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

Foreign exchange gains and losses resulting from settlement of transactions and from the translation at period-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognised in profit or loss.

All other foreign exchange gains and losses are presented in the Statement of comprehensive income within 'administrative expenses'.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

E.M.S ELECTRO MEDICAL SYSTEMS UK LIMITED (REGISTERED NUMBER: 11599365)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2025

2. ACCOUNTING POLICIES - continued

Provisions for liabilities
Provisions are recognised when an event has taken place that gives rise to a legal or constructive obligation, a transfer of economic benefits is probable and a reliable estimate can be made.

Provisions are measure as the best estimate of the amount required to settle the obligation, taking into account the related risks and uncertainties.

Increases in provisions are generally charged as an expense to profit or loss.

Financial instruments
The Company only enters into basic financial instruments transactions that result in the recognition of financial assets and liabilities such as trade and other receivables and payable, loans to related parties.

Financial assets
Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is identified, an impairment loss is recognised in profit and loss.

For financial assets measured at amortised cost, the impairment loss is measured as the difference between an asset's carrying amount and the present value of estimated cash flows discounted at the asset's original effective interest rate.

For financial assets measured at cost less impairment, the impairment loss is measured as the difference between an assets carrying amount and its recoverable amount, which is an estimate of the amount that the Company would receive for the asset if it were to be sold at the reporting date.

Financial liabilities
Basic financial liabilities, including trade and other payables are initially recognised at transition price, unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future receipts discounted at a rate of interest.

Trade payables are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if payment is due within one year or less, if not, they are presented as non-current liabilities. Trade payables are recognised initially at transaction price and subsequently measured at amortised cost.

Financial assets and liabilities are offset and the net amount reported in the Statement of financial position when there is an enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to readies the asset and settle the liability simultaneously.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 14 (2024 - 14 ) .

E.M.S ELECTRO MEDICAL SYSTEMS UK LIMITED (REGISTERED NUMBER: 11599365)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2025

4. TANGIBLE FIXED ASSETS
Improvements Fixtures
Loan to Plant and and
assets property machinery fittings Totals
£    £    £    £    £   
COST
At 1 January 2025 356,921 66,177 52,660 12,615 488,373
Additions - 36,778 21,708 4,537 63,023
At 31 December 2025 356,921 102,955 74,368 17,152 551,396
DEPRECIATION
At 1 January 2025 171,831 7,852 24,587 4,471 208,741
Charge for year 95,945 16,495 26,178 4,490 143,108
At 31 December 2025 267,776 24,347 50,765 8,961 351,849
NET BOOK VALUE
At 31 December 2025 89,145 78,608 23,603 8,191 199,547
At 31 December 2024 185,090 58,325 28,073 8,144 279,632

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.25 31.12.24
£    £   
Trade debtors 483,561 474,980
Other debtors 163,086 165,915
646,647 640,895

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.25 31.12.24
£    £   
Trade creditors 1,522,741 37,286
Amounts owed to group undertakings 2,501,149 3,039,782
Taxation and social security 199,485 175,269
Other creditors 116,367 179,778
4,339,742 3,432,115

7. DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006

The Report of the Auditors was unqualified.

Neil C Harding (Senior Statutory Auditor)
for and on behalf of Bradshaw Johnson

E.M.S ELECTRO MEDICAL SYSTEMS UK LIMITED (REGISTERED NUMBER: 11599365)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2025

8. ULTIMATE CONTROLLING PARTY

The immediate parent company is Manisa Holding SA, the address of its registered office is 34 Rue Saint - Maurice, Delemont, Switzerland.

The company's ultimate controlling party is Ferton Holding S.A, a company registered in Switzerland.